Products
Platform
Research
Market
Learn
Natco Pharma Ltd Financials Statements
Annual and Quarterly P/L, Balance Sheet, Cash Flow & Financial Ratios
Consolidate
Standalone
Total Qtr Revenue cr | 1,463.00 | 1,390.60 | 1,287.30 | 651.10 | 1,434.90 |
| Other Income Qtr Cr | 100.00 | 61.70 | 66.30 | 176.30 | 63.80 |
| Operating Revenues Qtr | 1,363.00 | 1,328.90 | 1,221.00 | 474.80 | 1,371.10 |
Loading chart... | |||||
Operating Expenses Qtr | 783.80 | 757.90 | 672.90 | 436.00 | 566.80 |
Operating Profit Qtr | 579.20 | 571.00 | 548.10 | 38.80 | 804.30 |
EBITDA Qtr Cr | 679.20 | 632.70 | 614.40 | 215.10 | 868.10 |
Depreciation Qtr | 52.40 | 57.60 | 98.30 | 47.00 | 45.80 |
Net Profit Qtr | 518.40 | 480.70 | 406.60 | 133.00 | 677.30 |
Basic EPS Qtr | 28.94 | 26.84 | 22.70 | 7.43 | 37.81 |
Open Demat Account
Open Demat Account